Hypochromic reticulocytes, hypochromic erythrocytes and p-transferrin receptors in diagnosing iron-deficient erythropoiesis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 64, Issue 8, 2004, Pages 691-702

  Starklint, Jørn ^a,b   Bech, J Nørgaard ^a   Aagaard, O ^b   Pedersen, E Bjerregaard ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

Anemia; Blood donation; Blood donors; End stage renal disease, erythropoietin; Healthy subjects

Indexed keywords

FERRITIN; IRON; PROTEIN DERIVATIVE; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DYSERYTHROPOIESIS; ERYTHROCYTE; FEMALE; HEMOCONCENTRATION; HEMODIALYSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; IRON DEFICIENCY ANEMIA; MALE; PRIORITY JOURNAL; RETICULOCYTE COUNT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; ANEMIA, HYPOCHROMIC; ERYTHROCYTES; ERYTHROPOIESIS; FEMALE; HEALTH; HUMANS; IRON; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN; RENAL DIALYSIS; RETICULOCYTES;

EID: 10644286579     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510410002940     Document Type: Article

References (18)

1. Van Zyl-Smit R. Diagnosis and management of iron deficiency in chronic dialysis patients. Curr Opin Nephrol Hypertens 2000; 9: 669-74.
2. Besarab A, Amin N, Ahsan M, Vogel S, Zazuwa G, Frinak S, Zazra J, Anandan J, Gupta A. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol 2000; 11: 530-8.
3. Cullen P, Söffker J, Höpfl M, Bremer C, Schlaghecken R, Mehrens T, Assmann G, Schaefer R. Hypochromic red cells and reticulocyte haemoglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis. Nephrol Dial Transplant 1999; 14: 659-65.
4. Tsuchiya K, Okano H, Teramura M, Iwamoto Y, Yamashita N, Suda A, Shimada K, Nihei H, Ando M. Content of reticulocyte hemoglobin is a reliable tool for determing iron deficiency in dialysis patients. Clin Nephrol 2003; 59: 115-23.
5. Schaefer RM, Schaefer L. Hypochromic red blood cells and reticulocytes. Kidney Int 1999; 55 Suppl 69: S44-8.
6. Mittmann N, Sreedhara R, Mushnick R, Chattopadhyay J, Zelmanovic D, Vaseghi M, Avram M. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 1997; 30: 912-22.
7. Macdougall IC. What is the most appropriate strategy to monitor functional iron deficiency in the dialyzed patient on rhEPO therapy? Nephrol Dial Transplant 1998; 13: 847-9.
8. Lorenzo JD, Rodriguez MM, Martin SS, Romo JMT. Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferro kinetic measurements. Am J Kidney Dis 2001; 37: 550-6.
9. D'Onofrio G, Chirillo R, Zini G, Caenaro G, Tommasi M, Micciulli G. Simultaneous measurement of reticulocyte and red blood cell indices in healthy subjects and patients with microcytic and macrocytic anemia. Blood 1995; 3: 818-23.
10. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
11. Brugnara C, Colella GM, Cremins J, Langley RC, Schneider TJ, Rutherford CJ, Goldberg MA. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis. J Lab Clin Med 1994; 123: 660-7.
12. Fishbane S, Galgano C, Langley RC, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-22.
13. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: iron-deficient erythropoiesis in iron-replete subjects. Blood 1993; 81: 956-64.
14. Schaefer RM, Schaefer L. Iron monitoring and supplementation: how do we achieve the best results? Nephrol Dial Transplant 1998; 13 Suppl 2: 9-12.
15. Silva J, Andrade S, Ventura H, Paulo J, Santos L, Colaco S, Oliveira C, Ponce P. Iron supplementation in haemodialysis: practical clinical guidelines. Nephrol Dial Transplant 1998; 13: 2572-7.
16. Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients. Nephrol Dial Transplant 1997; 12: 1173-81.
17. Sunder-Plassmann G, Spitzauer S, Hörl WH. The dilemma of evaluating iron status in dialysis patients: limitations of available diagnostic procedures. Nephrol Dial Transplant 1997; 12: 1575-80.
18. Tarng D, Huang T. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients. Nephrol Dial Transplant 2002; 17: 1063-9.